Cronos (CRON) Assets Average (2017 - 2026)
Cronos' (CRON) quarterly Assets Average came in at $1.2 billion in Q1 2026, up 2.12% year-on-year from $1.2 billion in Q1 2025, and little changed quarter-over-quarter from $1.2 billion in Q4 2025.
Cronos (CRON) Assets Average (2017 - 2026) Analysis & Trends
Cronos' Assets Average history runs 9 years deep, the most recent figure standing at $1.2 billion for Q1 2026.
- On a quarterly basis, Assets Average rose 2.12% year-over-year to $1.2 billion in Q1 2026; TTM through Mar 2026 was $1.2 billion, a 2.12% increase from a year earlier, with the FY2025 full-year figure at $1.2 billion, up 2.47% from the prior year.
- Assets Average steadied at $1.2 billion in Q1 2026 per CRON's latest filing, from $1.2 billion in the prior quarter.
- Across five years, Assets Average topped out at $1.4 billion in Q1 2022 and bottomed at $1.1 billion in Q2 2024.
- The 5-year median for Assets Average is $1.2 billion (2024), against an average of $1.2 billion.
- Across the five-year window, Assets Average dropped 27.27% in 2022 and increased 5.89% in 2025, its largest moves.
- Year by year, Assets Average stood at $1.2 billion in 2022, then decreased by 6.53% to $1.1 billion in 2023, then increased by 2.62% to $1.2 billion in 2024, then grew by 1.07% to $1.2 billion in 2025, then fell by 0.27% to $1.2 billion in 2026.
- Per Business Quant, the three latest CRON Assets Average figures stand at $1.2 billion (Q1 2026), $1.2 billion (Q4 2025), and $1.2 billion (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 43.72 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 40.39 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 15.32 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 99.52 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 7.30 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 68.63 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 37.01 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 4.77 Bn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 13.29 Bn |
| 10 | Cronos | 1.04 Bn | 267.78 Mn | 19.15 Mn | 1.18 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.18 Bn |
| Dec 31, 2025 | 1.19 Bn |
| Sep 30, 2025 | 1.18 Bn |
| Jun 30, 2025 | 1.16 Bn |
| Mar 31, 2025 | 1.16 Bn |
| Dec 31, 2024 | 1.18 Bn |
| Sep 30, 2024 | 1.14 Bn |
| Jun 30, 2024 | 1.10 Bn |
| Mar 31, 2024 | 1.12 Bn |
| Dec 31, 2023 | 1.15 Bn |
| Sep 30, 2023 | 1.16 Bn |
| Jun 30, 2023 | 1.16 Bn |
| Mar 31, 2023 | 1.19 Bn |
| Dec 31, 2022 | 1.23 Bn |
| Sep 30, 2022 | 1.28 Bn |
| Jun 30, 2022 | 1.35 Bn |
| Mar 31, 2022 | 1.38 Bn |
| Dec 31, 2021 | 1.47 Bn |
| Sep 30, 2021 | 1.57 Bn |
| Jun 30, 2021 | 1.74 Bn |